Back to News
Market Impact: 0.25
Bolt Biotherapeutics, Inc. Acquires Prana Therapies, Inc. and Secures $120 million Private Placement
Source: Nasdaq
M&A & RestructuringHealthcare & BiotechCompany Fundamentals
On October 23, 2026, Bolt Biotherapeutics acquired Prana Therapies through a stock-for-stock reverse merger. Bolt issued 430,746 common shares and 16,360.929 shares of a security described only as “Serie” in the truncated article; no transaction valuation or further terms are provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
BOLT0.00
More News
- With earnings in rearview mirror, SpaceX-Tesla merger chatter takes center stage
- Apple’s $2,000 iPhone Duo Debuts With Limited Supply
- Boeing 777 freighter output halted for two months over supplier row
- OpenAI Trims Target Value & Volvo Cars Cuts 2,500 Jobs
- Exclusive-Boeing supplier dispute has halted 777 freighter production for two months, sources say
- Volvo Cars shares plunge 25% amid China sales slump and fresh job cuts